Verano: Analysts Expect Q3 Revenues Of $219.7 Million

Verano Holdings (CSE: VRNO) announced that they will be reporting their third quarter financials before the market opens on November 16th.

Analysts have a consensus C$40.38 12-month price target on the company, via a total of 7 analysts, with 2 analysts having strong buy ratings, and the other 5 having buy ratings on the company. The street high comes from Beacon Securities with a C$47 price target, and the lowest target sits at C$35.

7 analysts have revenue estimates for the third quarter. The mean between all 7 is US$219.70 million; this number has been revised slightly down from US$224.82 million at the start of May. The street high is US$224.60 million while the lowest sits at US$210 million.

7 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 55.41%, with this number revised down from 60.72% at the start of May. Street high is a 58% estimate and the lowest sits at 53%.

Onto EBITDA estimates, there are currently 7 analysts who have third-quarter EBITDA estimates. The mean is currently US$85.64 million, with this number being revised down from US$100.17 million since the start of May. Street high sits at US$93.50 million EBITDA and the lowest being a US$63.70 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Tilray Sees Jefferies Lower Target Due To Canadian Cannabis Headwinds

Jefferies lowered their price target on Tilray Brands (TSX: TLRY), after updating their outlook, saying...

Sunday, April 10, 2022, 01:03:00 PM

Eight Capital Initiates Coverage On Field Trip Health With $10.20 Price Target

Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes...

Friday, September 17, 2021, 10:59:00 AM

NG Energy: Canaccord Initiates Coverage With $1.40 Price Target

Last week Canaccord Genuity Capital Markets’ initiated coverage on NG Energy (TSXV: GASX) with a...

Friday, July 22, 2022, 12:37:00 PM

Paypal: Consensus Revenue Estimates Climb To $5.9 Billion For Q1

Paypal Holdings (NASDAQ: PYPL) will be reporting its first quarter financial results today after the...

Wednesday, May 5, 2021, 11:42:00 AM

Well Health: Canaccord Slashes Price Target To $6

On May 11th, WELL Health Technologies Corp. (TSX: WELL) reported its first quarter financial results....

Wednesday, May 25, 2022, 04:11:00 PM